English  |  正體中文  |  简体中文  |  总笔数 :0  
造访人次 :  52963829    在线人数 :  880
教育部委托研究计画      计画执行:国立台湾大学图书馆
 
臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)
关于TAIR

浏览

消息

著作权

相关连结

"hsu c h"的相关文件

回到依作者浏览
依题名排序 依日期排序

显示项目 811-820 / 1656 (共166页)
<< < 77 78 79 80 81 82 83 84 85 86 > >>
每页显示[10|25|50]项目

机构 日期 题名 作者
臺大學術典藏 2020-05-25T07:35:20Z Postchemoradiotherapy pathologic stage classified by the American joint committee on the cancer staging system predicts prognosis of patients with locally advanced esophageal squamous cell carcinoma Guo J.-C; Huang T.-C; Chia-Chi Lin; Hsieh M.-S; Chang C.-H; Huang P.-M; Lee J.-M; Hsu F.-M; Cheng J.C.-H; Wang H.-P; Yeh K.-H; Cheng A.-L; Hsu C.-H.
臺大學術典藏 2020-05-25T07:35:15Z A role of multimodality bladder-preserving therapy in patients with muscle-invasive bladder cancer plus hydronephrosis with or without pelvic nodal involvement Chiang Y; Cheng J.C.-H; Huang C.-Y; Tsai Y.-C; Chia-Chi Lin; Hsu C.-H; Cheng A.-L; Pu Y.-S.
臺大學術典藏 2020-05-25T07:35:12Z Response to Nivolumab as Salvage Therapy in a Patient with Thymic Carcinoma Yang P.-C; Guo J.-C; Hsieh M.-S; Chia-Chi Lin; Hsu C.-H.
臺大學術典藏 2020-05-25T07:35:12Z Do We Need to Add Postoperative Radiotherapy in Patients Undergoing Trimodality Therapy for Esophageal Squamous Cell Carcinoma with Positive Lymph Nodes Disease? Huang P.-M; Hsu F.-M; Chia-Chi Lin; Hsu C.-H; Cheng J.C.-H; Lee J.-M.
臺大學術典藏 2020-05-25T07:35:12Z Number of resected lymph nodes and survival of patients with locally advanced esophageal squamous cell carcinoma receiving preoperative chemoradiotherapy Guo J.-C; Chia-Chi Lin; Huang T.-C; Huang P.-M; Kuo H.-Y; Chang C.-H; Wang C.-C; Cheng J.C.-H; Yeh K.-H; Hsu C.-H; Lee J.-M.
臺大學術典藏 2020-05-25T07:35:05Z Improved prognosis with induction chemotherapy in pathological complete responders after trimodality treatment for esophageal squamous cell carcinoma: Hypothesis generating for adjuvant treatment Cheng J.C.-H.;Hsieh M.-S;Chang Y.-L;Chia-Chi Lin;Hsu C.-H;Huang P.-M;Lee J.-M;Tsai C.-L;Hsu F.-M;Lu S.-L; Lu S.-L; Hsu F.-M; Tsai C.-L; Lee J.-M; Huang P.-M; Hsu C.-H; Chia-Chi Lin; Chang Y.-L; Hsieh M.-S; Cheng J.C.-H.
臺大學術典藏 2020-05-25T07:35:05Z Phase II study of metabolic response to one-cycle chemotherapy in patients with locally advanced esophageal squamous cell carcinoma Huang T.-C; Chia-Chi Lin; Wu Y.-C; Chia-Hsien Cheng J; Lee J.-M; Wang H.-P; Huang P.-M; Hsu F.-M; Yeh K.-H; Cheng A.-L; Tzen K.-Y; Hsu C.-H.; Hsu C.-H.;Tzen K.-Y;Cheng A.-L;Yeh K.-H;Hsu F.-M;Huang P.-M;Wang H.-P;Lee J.-M;Chia-Hsien Cheng J;Wu Y.-C;Chia-Chi Lin;Huang T.-C
臺大學術典藏 2020-05-25T07:35:01Z A phase I study of pexidartinib, a colony-stimulating factor 1 receptor inhibitor, in Asian patients with advanced solid tumors Chia-Chi Lin;Tajima N;Oguma T;Ishizuka T;Sugihara M;Chiu L.Y;Sasaki S.-I;Cheng A.-L;Yang J.C.-H;Yen Y.-H;Hsu C.-H;Chen T.W.-W;Lee J.-H; Lee J.-H; Chen T.W.-W; Hsu C.-H; Yen Y.-H; Yang J.C.-H; Cheng A.-L; Sasaki S.-I; Chiu L.Y; Sugihara M; Ishizuka T; Oguma T; Tajima N; Chia-Chi Lin
臺大學術典藏 2020-05-25T07:35:00Z Two first-in-human studies of xentuzumab, a humanised insulin-like growth factor (IGF)-neutralising antibody, in patients with advanced solid tumours Bogenrieder T; Twelves C; Cheng A.-L.; Huang D.C.-L; Strelkowa N; Goeldner R.-G; Schmid U; Fuertig R; Buschke S; Jove M; Anthoney A; Yen C.-J; de Bono J; Chia-Chi Lin; Chen L.-T; Corral J; Michalarea V; Rihawi K; Ong M; Lee J.-H; Hsu C.-H; Yang J.C.-H; Shiah H.-S
臺大學術典藏 2020-05-25T06:52:11Z A phase II study of weekly methotrexate, cisplatin, and 24-hour infusion of high-dose 5-fluorouracil and leucovorin (MP-HDFL) in patients with metastatic and recurrent esophageal cancer-improving toxicity profile by infusional schedule and double biochemical modulation of 5-fluorouracil Hsu C; Yang C.-H; YEN-SHEN LU; Lin C.-C; Bu C.-F; Yeh K.-H.; Yeh K.-H.;Bu C.-F;Lin C.-C;Yen-Shen Lu;Yang C.-H;Hsu C;Cheng A.-L;Hsu C.-H; Hsu C.-H; Cheng A.-L

显示项目 811-820 / 1656 (共166页)
<< < 77 78 79 80 81 82 83 84 85 86 > >>
每页显示[10|25|50]项目